Amgen Inc. logo

AMGN

Amgen Inc.

$377.35
-1.34%
Last updated 1:04 AM
Amgen Inc logo

Amgen Inc

Amgen Inc is a Biotechnology company listed on NASDAQ NMS - GLOBAL MARKET.

Industry
Biotechnology
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$204.0B
P/E Ratio
23.3
Cash on Hand
$9.1B(positive)
Shares Outstanding
539.7M shares
Currency
USD
Visit website →

About

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$5.73$6.29
Q1 2026$4.85$5.15
Q4 2025$4.83$5.29
Q3 2025$5.11$5.64

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$269.77 – $447.03

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
3.21%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
22.9%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+9.1%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.46

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 43 analysts

Next Earnings
Nov 2, 2026

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Khosla Rachna
Aug 13, 2026 • $162.60/share
Bought 1,252
Khosla Rachna
Aug 13, 2026 • $416.43/share
Sold 1,252
Khosla Rachna
Aug 13, 2026
Sold 1,252
Khosla Rachna
Aug 11, 2026 • $412.57/share
Sold 2,000
HOLLEY CHARLES M
Aug 7, 2026
Bought 103
ISHRAK OMAR
Aug 7, 2026
Bought 85

Recent News